Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Koerner

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Transplantation|October 26, 1999
Hemodynamic follow-up of cardiac allografts from donors undergoing hemodialysis for chronic renal failureG Tenderich, M M Koerner, R P Koerfer
The Heart Surgery Forum|January 6, 2017
Pump Thrombosis following HeartMate II Left Ventricular Assist Device Implantation in a Patient with Aspirin and Plavix ResistanceAli Ghodsizad, A Badiye, M Zeriouh, et al.
Surgery Today|June 29, 2001
Influence of cytoimmunological state on the development of tuberculosis in heart transplant recipientsN Hirata, M M Koerner, G Tenderich, et al.
Journal of Toxicology. Clinical Toxicology|January 1, 1997
Heart donation after fatal acetaminophen poisoningP Hantson, M C Vekemans, P F Laterre, et al.
Cardiology Clinics|November 22, 2001
Managing heart failure with immunomodulatory agentsK A Lisman, S J Stetson, M M Koerner, et al.
Current Opinion in Cardiology|August 22, 2000
Cardiac transplantation: the final therapeutic option for the treatment of heart failureM M Koerner, J B Durand, J A Lafuente, et al.
Heart Failure Reviews|April 20, 2001
The effect of cytokines on cardiac allograft function: tumor necrosis factor alpha a mediator of chronic injuryA Perez-Verdia, S J Stetson, S McRee, et al.
British Journal of Haematology|May 1, 1997
Heart transplantation for end-stage heart failure caused by iron overloadM M Koerner, G Tenderich, K Minami, et al.
The Heart Surgery Forum|December 23, 2017
Extracorporeal Membrane Oxygenation (ECMO): An Option for Cardiac Reccovery from Advanced Cardiogenic ShockAli Ghodsizad, Kai Singbartl, Matthias Loebe, et al.
Transplantation Proceedings|June 24, 1998
Does preexisting elevated pulmonary vascular resistance (transpulmonary gradient > 15 mm Hg or > 5 wood) predict early and long-term results after orthotopic heart transplantation?G Tenderich, M M Koerner, B Stuettgen, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Transplantation|October 26, 1999
Hemodynamic follow-up of cardiac allografts from donors undergoing hemodialysis for chronic renal failureG Tenderich, M M Koerner, R P Koerfer
The Heart Surgery Forum|January 6, 2017
Pump Thrombosis following HeartMate II Left Ventricular Assist Device Implantation in a Patient with Aspirin and Plavix ResistanceAli Ghodsizad, A Badiye, M Zeriouh, et al.
Surgery Today|June 29, 2001
Influence of cytoimmunological state on the development of tuberculosis in heart transplant recipientsN Hirata, M M Koerner, G Tenderich, et al.
Journal of Toxicology. Clinical Toxicology|January 1, 1997
Heart donation after fatal acetaminophen poisoningP Hantson, M C Vekemans, P F Laterre, et al.
Cardiology Clinics|November 22, 2001
Managing heart failure with immunomodulatory agentsK A Lisman, S J Stetson, M M Koerner, et al.
Current Opinion in Cardiology|August 22, 2000
Cardiac transplantation: the final therapeutic option for the treatment of heart failureM M Koerner, J B Durand, J A Lafuente, et al.
Heart Failure Reviews|April 20, 2001
The effect of cytokines on cardiac allograft function: tumor necrosis factor alpha a mediator of chronic injuryA Perez-Verdia, S J Stetson, S McRee, et al.
British Journal of Haematology|May 1, 1997
Heart transplantation for end-stage heart failure caused by iron overloadM M Koerner, G Tenderich, K Minami, et al.
The Heart Surgery Forum|December 23, 2017
Extracorporeal Membrane Oxygenation (ECMO): An Option for Cardiac Reccovery from Advanced Cardiogenic ShockAli Ghodsizad, Kai Singbartl, Matthias Loebe, et al.
Transplantation Proceedings|June 24, 1998
Does preexisting elevated pulmonary vascular resistance (transpulmonary gradient > 15 mm Hg or > 5 wood) predict early and long-term results after orthotopic heart transplantation?G Tenderich, M M Koerner, B Stuettgen, et al.
Pageof 3